Photo coming soon
Thymosin Alpha-1
Shipping and payment
Chemistry & specifications
Reference data from public databases. For research use only.
| CAS Number | 62304-98-7 |
|---|---|
| Molecular Formula | C129H215N33O55 |
| Molecular Weight | 3108.3 g/mol |
| Residue Count | 28 |
| Sequence (1-letter) | SDAAVDTSSEITTKDLKEKKEVVEEAEN |
| PubChem CID | 16130571 → |
Common questions
What pack sizes and strengths are available for Thymosin Alpha-1?
Thymosin Alpha-1 is offered as a 2-vial kit, a single vial, or a 10-vial box. Available strengths: 5 mg and 10 mg per vial. Every vial in a kit or box is the strength you select. The price per vial for each pack is shown under the price.
How quickly does Thymosin Alpha-1 ship?
Thymosin Alpha-1 is prepared to order, so it is dispatched within 7 business days of your order. Carrier transit then takes up to 3 business days within the contiguous United States. Standard shipping is a $18.99 flat rate and free on orders over $200.
How should Thymosin Alpha-1 be stored?
Lyophilized (freeze-dried) vials tolerate normal shipping at room temperature. On arrival, keep them sealed, dry and away from light: a refrigerator at about 4 °C for the short term, or −20 °C or colder for long-term storage. Let a cold vial reach room temperature before opening it so moisture does not condense on the powder.
How do I work out the concentration after reconstitution?
Concentration in mg/mL equals the vial amount in mg divided by the mL of solvent added. Our free reconstitution calculator also shows the mg held at each 0.1 mL mark.
Is Thymosin Alpha-1 for human use?
No. Thymosin Alpha-1 is sold strictly for laboratory research use. It is not a drug, food, dietary supplement, or cosmetic, has not been evaluated by the FDA, and is not for human or veterinary use. Purchasers must be 21 or older.
Research background
Chemistry, identity, and a summary of the peer-reviewed literature on Thymosin Alpha-1.
Read the Thymosin Alpha-1 research background → Reconstitution calculator →Peer-reviewed research
Every research claim on this page traces to one of the 4 publications below.
- Immune Modulation with Thymosin Alpha 1 TreatmentVitam Horm (2016)View publication →
- Thymosin alpha-1 treatment in chronic hepatitis BExpert Opin Biol Ther (2015)View publication →
- Thymosin alpha-1Am J Health Syst Pharm (2001)View publication →
- Thymosin α-1 in cancer therapy: Immunoregulation and potential applicationsInt Immunopharmacol (2023)View publication →



